Recent Articles from Investor Brand Network

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

NanoViricides, Inc. (NYSE American: NNVC) announced that it has shipped NV-387 Oral Gummies to the Democratic Republic of Congo in preparation for a Phase II clinical trial evaluating the drug as a treatment for MPox. The company said site preparations are being conducted by its contract research organization, Om Sai Clinical Research Pvt. Ltd., and local partners, with patient enrollment and dosing expected to begin following completion of staff training in the coming weeks.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Researchers at Northwestern Medicine have identified immune system markers that may help predict who responds to BCG bladder cancer therapy and who does not. The Journal of Clinical Investigation published the findings.

Dynamic Global Events (“DGE”) will host the 6th Chief Patient Officer Summit on July 23–24, 2026, at the Sheraton Boston Hotel in Boston, Massachusetts.

On Wednesday, the U.S. Fed completed its latest FOMC meeting with a decision to keep benchmark lending rates at their current level due to uncertainty about inflationary pressures arising from high energy prices due to the Middle East conflict. However, the policymakers signaled that there could be a rate hike later this year if inflation doesn’t slow down.

BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP inhibitor. DDRi therapies collectively represented an estimated $7-plus billion in global sales in 2025, and the broader oncology, diagnostics and precision medicine markets are projected to climb to roughly $750 billion by 2030. New inhibitor classes are emerging as the next major wave. Sitting at the forefront of this shift is Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF), ( Profile ) a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor that targets a DNA repair enzyme involved in multiple DNA repair pathways. As the field races to find the next generation of synthetic lethality assets, Onco-Innovations occupies a unique space as it strengthens its position in the biopharmaceutical and biotechnology sector, along with other leading companies, such as AstraZeneca plc (NYSE: AZN), Aprea Therapeutics Inc. (NASDAQ: APRE), Boundless Bio Inc. (NASDAQ: BOLD) and Foghorn Therapeutics Inc. (NASDAQ: FHTX), that are focused on developing therapies for serious…

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More than 2.9 million people worldwide are living with MS today, and despite decades of research, every approved treatment falls short of the same fundamental goal: stopping the disease cold. Current therapies can slow progression, but they cannot halt it, and for millions of patients, that gap means a future of worsening disability. Now, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ( Profile ) is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly targeting the myelin sheath that MS destroys, and this new drug candidate is preparing to enter phase 2 clinical trials. Quantum BioPharma is one of several companies focused on the development and commercialization of therapies for neurological, autoimmune and immune-mediated diseases, including Sanofi (NASDAQ: SNY), Roche Holding AG (OTCQX: RHHBY), Biogen Inc. (NASDAQ: BIIB) and…

Energy capital allocation is undergoing a historic transformation that’s favoring renewable technologies over conventional fossil fuels. According to the International Energy Agency’s latest World Energy Investment analysis, clean power infrastructure has attracted substantially greater funding than traditional energy projects through 2026, marking a fundamental shift in global investment patterns.

Nocera (NASDAQ: NCRA) provided additional details regarding its minority equity investment in CampaignPulse.ai, an artificial intelligence-driven platform being developed to help organizations simulate audience responses, test messaging strategies and evaluate campaign effectiveness before committing resources to real-world deployment. The platform is expected to leverage large language models, predictive analytics and simulation-based modeling to support applications across political campaigns, corporate communications, public affairs, fundraising, investor relations, marketing and reputation management.

A major shift is about to reshape Europe’s crypto sector as the transition period under the Markets in Crypto-Assets (MiCA) regulation ends on July 1. The deadline marks the conclusion of an 18-month grace period that allowed firms previously operating under national registration systems to obtain authorization under the EU’s new regulatory framework.

Artificial intelligence is changing the way people shop online. Businesses are using AI to improve customer service, create product descriptions, recommend products, and automate many parts of ecommerce. While these tools can make shopping more convenient, a new study suggests that AI is also creating new concerns for consumers.

Nightfood Holdings (OTCQB: NGTF) operating through its TechForce Robotics division, was featured in a NetworkNewsAudio Audio Press Release highlighting the growing demand for automation solutions driven by the global buildout of artificial intelligence infrastructure. The editorial notes that major technology companies are expected to invest hundreds of billions of dollars in AI-related infrastructure, creating downstream opportunities for companies providing manufacturing, engineering and precision automation systems.

Exploring the concepts, products and innovations influencing currencies, digital assets and global finance.

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide

Xeriant (OTCQB: XERI) announced an upcoming production run of its patented NEXBOARD(TM) composite building panels, marketed under the DUREVER(TM) line of sustainable construction materials. The production campaign follows the recent achievement of Class A ASTM E84 and NFPA 286 fire safety certifications and is intended to fulfill sample requests from multiple leading homebuilders and commercial construction firms evaluating the product for future projects.

M-tron Industries (NYSE American: MPTI) announced a $6.8 million follow-on order from a U.S. Department of Defense contractor supporting multiple counter-unmanned aircraft system (“C-UAS”) radar programs. The order includes several products, including high-performance oven-controlled crystal oscillators, with work scheduled to be performed in Orlando, Florida, through 2027.

This article has been disseminated on behalf of Knight Therapeutics Inc. and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity.

VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity.

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide

FingerMotion (NASDAQ: FNGR) announced that it and BlueFlare Energy Solutions are in advanced discussions regarding commercial terms for the first of two proposed behind-the-meter AI compute projects identified under their previously announced memorandum of understanding. The initial project is a roughly 600-kilowatt Alberta facility that currently uses natural gas that would otherwise be flared to power bitcoin mining operations, with plans to redevelop the site into an AI inference facility supported by new on-site power generation, battery energy storage and high-performance computing infrastructure.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced that its previously disclosed acquisition of NOMAD Transportable Power Systems is expected to close on or about July 1, 2026, subject to customary conditions and approvals. Ahead of closing, LIXTE will provide a $6.5 million loan to NOMAD to support procurement of long-lead components, fund working capital and help the company scale manufacturing against its growing order pipeline for deployable utility-grade battery energy storage systems.

Earth Science Tech (OTC: ETST) is capturing the attention of the micro-cap market following a significant acceleration of its share repurchase program. Recent market data indicates that the company is aggressively buying back its own stock, a strategic corporate move that typically signals strong internal confidence in a company’s financial health, cash flow, and future trajectory.

Wearable Devices (NASDAQ: WLDS) announced that Founder and Chief Scientific Officer Guy Wagner will deliver a keynote presentation at AWE USA 2026 in Long Beach, California, titled “How BCI is Removing the Friction from AR and AI Interaction.” The session will explore how brain-computer interface technologies, including wrist-worn neural sensing combined with biosignals such as inertial measurement unit and photoplethysmography data, can help bridge the gap between human intent and machine understanding in artificial intelligence and augmented reality environments.

Earth Science Tech (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, highlighted by revenue of $35.7 million, up 8% from the prior year, gross profit of $25.5 million, up 5%, and net income of $3.6 million, an 11% increase compared with fiscal 2025. Total assets rose 27% year over year to $9.0 million as the company continued expanding its integrated healthcare platform across telemedicine, pharmacy and fulfillment services.

American Fusion (OTC: AMFN) announced that members of its engineering and leadership teams have arrived in Texas to accept delivery of the company’s 5MW Pre-Production Texatron Fusion Engine, a milestone that follows the completion of final fabrication and modification activities. The system is expected to be transported to the Dallas-Fort Worth Metroplex, where installation, commissioning and testing activities are planned as the company advances development of its proprietary aneutronic fusion technology.

Gold has endured another challenging stretch, leaving many investors disappointed as prices continue to struggle and drift deeper into bear market territory. While sentiment remains cautious in the short term, the broader economic landscape may be evolving in a way that eventually transforms one of gold’s biggest obstacles into a powerful source of support.

Britain is preparing to scale down its EV sales requirements, with a formal consultation underway on what a new 2030 share should look like. Current targets state that 80% of new car sales must be electric by 2030, but a revised figure somewhere between 50% and 70% is being considered. Reaching a final number is expected to take several months.

Last year, Congress passed changes to Medicaid eligibility requirements and CMS was given a deadline to issue final rules on those work requirements. The federal agency has since published those final rules and enrollees on the Medicaid program need to acquaint themselves with these requirements to ensure they comply in order to retain their eligibility. We discuss some of those requirements.

A wave of job cuts across the tech sector might seem like evidence that AI is already replacing large numbers of workers. Yet a closer look suggests the economics behind AI adoption remain far more complicated.

Greenland Mines (NASDAQ: GRML) announced the engagement of Tetra Tech Canada Inc. and GeoSim Services Inc. to prepare an updated SEC S-K 1300-compliant mineral resource estimate for its Sarfartoq neodymium-praseodymium rare earth project in southwest Greenland. The updated resource estimate, expected to be substantially completed this summer, will incorporate historical NI 43-101 resource work along with drilling and technical studies completed by Neo Performance Materials between 2023 and 2025, and is intended to support an updated preliminary economic assessment and future development studies.

A new analysis conducted by TechInsights has found that the AI boom is driving the semiconductor market towards a $2 trillion valuation by 2027. The report shows that technology roadmaps, supply chains and industry economics are being fundamentally transformed as a result of this boom.

Britain is accelerating clean energy deployment through a streamlined grid connection process that contrasts sharply with American regulatory delays hampering the global transition. The UK’s power planning body recently granted access to the grid for over 700 renewable and battery storage projects, a development projected to unlock approximately $50 billion in annual clean power investment across multiple sectors.

The UFC recently revealed that select athletes competing at the White House mixed martial arts showcase will receive performance bonuses in a crypto created by World Liberty Financial (WLF), a company linked to President Donald Trump’s family.

Standard Chartered believes that the cryptocurrency market may finally be moving past one of its toughest periods. After months of falling prices and weak investor confidence, the bank says Bitcoin may have already reached the lowest point of the current market cycle. This has raised hopes that the long crypto winter could be coming to an end.

Holding digital assets was once largely viewed as a passive strategy centered on long-term appreciation, inflation protection and portfolio diversification. Today, however, institutional investors are increasingly focused on a different objective: generating productive returns from digital asset holdings while maintaining the oversight, security and liquidity standards expected in traditional finance.

Nightfood Holdings (OTCQB: NGTF) announced its placement in an AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is driving demand for automation and robotics solutions across multiple industries. The article highlights the massive capital investment flowing into AI data centers, semiconductor production and related infrastructure, while noting that physical construction, power deployment and operational support have emerged as key constraints on future growth.

VERAXA Biotech (NASDAQ: VRXA) announced new in vitro proof-of-concept data supporting its novel BiTAC(TM)-ADC technology platform, which is designed to improve precision in cancer treatment through tumor-restricted activation of therapeutic agents. The company reported that BiTAC-ADCs demonstrated the ability to distinguish between breast cancer and healthy cells and achieved dose-dependent killing of 3D tumor cell spheroids while minimizing toxicity through the use of separately delivered, systemically inactive precursor components.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) announced the launch of its artificial intelligence-powered good manufacturing practices manufacturing services platform at the 2026 BIO International Convention in San Diego. The platform combines the company’s PDAOAI technology with advanced robotics provided through its collaboration with TechForce Robotics to support pharmaceutical, biotechnology and advanced therapeutics companies seeking to modernize manufacturing operations through AI-driven workflows, digital quality systems and intelligent automation.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article. “The company’s vision reflects a broader shift taking place across the healthcare industry toward predictive and precision medicine. Cardio Diagnostics envisions a healthcare system where every patient receives individualized care informed by their unique molecular insights and where heart disease is no longer the world’s leading killer. Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing, and improved accessibility, all areas the company has identified as foundational pillars of its strategy.”

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) and may include paid advertising.

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) and may include paid advertising.

Wearable Devices (NASDAQ: WLDS) announced that it will implement a 1-for-3 reverse share split of its ordinary shares and publicly traded warrants, effective at the opening of trading on June 22, 2026. The company said the reverse split is intended to increase the per-share trading price of its ordinary shares and regain compliance with Nasdaq’s $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.

American Fusion (OTC: AMFN) announced that Robert V. Duncan, Ph.D., has agreed to serve as an independent scientific and strategic advisor to the company as it advances development of its Texatron(TM) Fusion Engine(TM) platform. Duncan is a physicist, inventor and research executive whose career includes leadership roles at Texas Tech University, the University of Missouri, Sandia National Laboratories and the New Mexico Consortium at Los Alamos National Laboratory, as well as service on federal scientific advisory boards and National Academy of Sciences panels.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

ParaZero Technologies (NASDAQ: PRZO) announced it has received an additional order for its DefendAir Net Pod system from a second business unit within a Tier-1 Israeli-based global defense company. The order is intended to support integration of the DefendAir Net Pod into the customer’s autonomous ground-based Counter-UAS platform and includes dedicated engineering integration services from ParaZero.

On Monday, precious metal prices ticked upwards. Gold reached $4,362 an ounce, marking gains of approximately 3.4%. Silver’s price hit $71.2 an ounce, a rally of about 4.7%. We look at some of the key factors that are driving this rally in precious metal prices as this week progresses.

Despite a warning from President Donald Trump earlier this year urging states to avoid regulating AI, state lawmakers across the country are continuing to pursue their own rules governing the rapidly expanding technology.

AINewsWire Editorial Coverage : The worldwide push to build out artificial intelligence infrastructure has set off a wave of capital spending across the tech industry unmatched in recent memory. Major cloud companies are pouring hundreds of billions of dollars into data centers, global semiconductor sales reached $791.7 billion in 2025 and are on track to near $1 trillion this year 2026, and McKinsey’s latest State of AI report confirms that generative AI could contribute between $2.6 trillion and $4.4 trillion each year to the global economy across 63 distinct applications. Even so, as this expansion gathers pace, a less-discussed but critical theme is surfacing: The physical groundwork needed to construct, supply power to and run AI systems is turning into the main limit on how quickly this transformation can unfold. With this in mind, Nightfood Holdings Inc. (OTCQB: NGTF) ( Profile ), operating under the name TechForce Robotics, is focused on building AI-driven automation tools for hospitality, pharmaceutical, lab and industrial settings. TechForce recently announced a partnership with Jiun Jiang (“JJ Enterprise”) aimed at advancing AI infrastructure, chip-manufacturing automation and pharmaceutical robotics, placing the company directly within one of today’s most significant growth trends in technology. The company aims to become a notable name within the AI infrastructure and advanced computing space, alongside other major participants such as Super Micro Computer Inc. (NASDAQ: SMCI), Palantir Technologies Inc. (NASDAQ: PLTR), Applied Materials Inc. (NASDAQ: AMAT) and…

With a 2026 drilling window fast approaching and $70 million in fresh capital already secured, Greenland Energy (NASDAQ: GLND) is making a compelling argument that the Jameson Land Basin in East Greenland, one of the largest undeveloped Arctic hydrocarbon positions in the world, is no longer a story about geological potential but about execution. In an updated investor presentation, the Houston-based energy exploration company outlines in detail its proposed strategy to advance exploration of the Jameson Land Basin through modern technology, a clearly defined earn-in structure and a set of near-term drilling catalysts that management believes are achievable within the current calendar year.

VolitionRx Limited (NYSE American: VNRX) announced a collaboration with Sysmex (TYO: 6869) to optimize Volition’s Nu.Q® NETs H3.1 assay on the Sysmex diagnostic platform. The agreement supports Volition’s strategy of licensing its proprietary Nu.Q® NETs technology to established global diagnostics companies that can leverage their disease expertise, regulatory capabilities and installed analyzer base to accelerate development and commercialization.

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, announced the advancement of Phase 2 objectives under its joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the deployment of PUR-E, an autonomous clean room support robot, within SAPU Bio’s OEB-5 sterile injectable cGMP facility. The deployment expands the initiative beyond Phase 1 materials logistics operations and into sterile manufacturing and clean room environments, where TechForce and Oncotelic are evaluating robotics, automation and AI-driven technologies to support regulated pharmaceutical workflows.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) operating through TechForce Robotics, is featured in a new AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is increasing demand for advanced automation, robotics and precision manufacturing solutions. The report highlights TechForce’s recent partnership with Jiun Jiang (“JJ Enterprise”) to advance AI infrastructure, semiconductor manufacturing automation and pharmaceutical robotics, positioning the company alongside major AI ecosystem participants including Super Micro Computer Inc. (NASDAQ: SMCI), Palantir Technologies Inc. (NASDAQ: PLTR), Applied Materials Inc. (NASDAQ: AMAT) and KLA Corporation (NASDAQ: KLAC).

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) announced the completion of key Phase 2 objectives in its manufacturing automation initiative with TechForce Robotics, advancing commercialization of an AI-powered good manufacturing practices manufacturing services platform at SAPU Bio, the company’s 45%-owned sterile injectable cGMP manufacturing joint venture. The Phase 2 deployment expands the capabilities of Oncotelic’s proprietary PDAOAI(TM) platform across sterile manufacturing operations, electronic batch records, GMP workflow execution, cleanroom monitoring and autonomous materials movement.

Exploring the concepts, products and innovations influencing currencies, digital assets and global finance.

SpaceX (NASDAQ: SPCX) briefly surpassed Amazon.com in market capitalization on June 16 as investors continued piling into shares following the company’s record-setting initial public offering, according to a Reuters report. Reuters reported that shares of Elon Musk’s rocket, satellite and artificial intelligence company climbed as much as 10%, pushing its valuation above $2.7 trillion and, at one point, ahead of both Amazon and Microsoft among the world’s most valuable companies. The surge was fueled in part by the launch of options trading in SpaceX shares and growing investor enthusiasm surrounding the company’s expanding presence in space technology, communications and artificial intelligence.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its significant transformation over the past several years, positioning as a diversified holding company focused on pharmaceutical compounding, telemedicine, healthcare services, and strict capital allocation. “The company recently completed a vertically integrated telehealth and pharmacy ecosystem through the launch of MyOnlineConsultation.com, with telemedicine capabilities supporting patient acquisition, while pharmacy operations drive high-margin recurring prescription-based revenue streams,” reads a recent article. “Above all, Earth Science Tech emphasizes balance-sheet strength and capital discipline through ongoing share repurchase initiatives designed to reduce dilution and support shareholder value.”